Literature DB >> 3390332

Paragangliomas of the head and neck.

K M Hodge1, R M Byers, L J Peters.   

Abstract

The medical records of 64 patients with paraganglioma of the head and neck seen between 1954 and 1984 at the University of Texas M.D. Anderson Hospital, Houston, were reviewed. Lesions were found in the carotid body (n = 24), jugulotympanic area (n = 37), vagal nerve (n = 4), and larynx (n = 1). A hereditary pattern was identified in six patients (9%). Metastases developed and caused the death of two patients (8%). No functional secreting tumors were identified. Paragangliomas are often misdiagnosed, both clinically and pathologically. Angiography is the definitive clinical study for diagnosis and treatment planning. Computed tomographic scanning further defines extent of the disease. Lesions in the neck are effectively treated by surgery. Jugulotympanic tumors can be successfully managed by surgery, radiation therapy, or a combination of both depending on the size and extent of the tumor. Secondary treatment of residual disease can be as effective as primary treatment.

Entities:  

Mesh:

Year:  1988        PMID: 3390332     DOI: 10.1001/archotol.1988.01860200056018

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  12 in total

1.  Catecholamine-secreting paragangliomas at the skull base.

Authors:  R Kuhweide; M J Lanser; U Fisch
Journal:  Skull Base Surg       Date:  1996

2.  Characterization of Malignant Head and Neck Paragangliomas at a Single Institution Across Multiple Decades.

Authors:  Hilary C McCrary; Eric Babajanian; Matias Calquin; Patrick Carpenter; Geoffrey Casazza; Anne Naumer; Samantha Greenberg; Wendy Kohlmann; Richard Cannon; Marcus M Monroe; Jason P Hunt; Luke Buchmann
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-07-01       Impact factor: 6.223

Review 3.  Paragangliomas of the head and neck: diagnosis and treatment.

Authors:  C C Boedeker; G J Ridder; J Schipper
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 4.  Primary paraganglioma of thyroid gland: a clinicopathologic and immunohistochemical study with review of the literature.

Authors:  E Ferri; R Manconi; E Armato; F Ianniello
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-04       Impact factor: 2.124

5.  Carotid body tumor associated with differentiated thyroid carcinoma.

Authors:  Y Kuratomi; Y Kumamoto; Y Sakai; S Komiyama
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

6.  Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy.

Authors:  Carlos Suárez; Juan P Rodrigo; William M Mendenhall; Marc Hamoir; Carl E Silver; Vincent Grégoire; Primož Strojan; Hartmut P H Neumann; Rupert Obholzer; Christian Offergeld; Johannes A Langendijk; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-19       Impact factor: 2.503

7.  Paraganglioma of the thyroid gland: cytologists' enigma.

Authors:  Kafil Akhtar; Prasenjit Sen Ray; S Shamhsad Ahmad; Rana K Sherwani
Journal:  BMJ Case Rep       Date:  2013-05-22

8.  External Auditory Canal Paraganglioma with Chronic Otitis Media of Ear: A Rare Coexistence.

Authors:  Pradeep Pradhan; Swagatika Samal; C Preetam; Pradipta Parida
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-02-19

Review 9.  Paraganglioma of the cerebellum: case report and review of the literature.

Authors:  Mirko Nitsche; Marco Prinz; Robert Michael Hermann; Hans Christiansen; Elisabeth Weiss
Journal:  Int J Clin Oncol       Date:  2005-12       Impact factor: 3.850

Review 10.  Head and neck paragangliomas: clinical and molecular genetic classification.

Authors:  Christian Offergeld; Christoph Brase; Svetlana Yaremchuk; Irina Mader; Hans Christian Rischke; Sven Gläsker; Kurt W Schmid; Thorsten Wiech; Simon F Preuss; Carlos Suárez; Tomasz Kopeć; Attila Patocs; Nelson Wohllk; Mahdi Malekpour; Carsten C Boedeker; Hartmut P H Neumann
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.